vTv Therapeutics Inc
NASDAQ:VTVT

Watchlist Manager
vTv Therapeutics Inc Logo
vTv Therapeutics Inc
NASDAQ:VTVT
Watchlist
Price: 29.01 USD 6.07%
Market Cap: 114.3m USD

Wall Street
Price Targets

VTVT Price Targets Summary
vTv Therapeutics Inc

Wall Street analysts forecast VTVT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTVT is 37.74 USD with a low forecast of 35.35 USD and a high forecast of 42 USD.

Lowest
Price Target
35.35 USD
22% Upside
Average
Price Target
37.74 USD
30% Upside
Highest
Price Target
42 USD
45% Upside
vTv Therapeutics Inc Competitors:
Price Targets
AMGN
Amgen Inc
3% Upside
KRYS
Krystal Biotech Inc
2% Downside
ARQT
Arcutis Biotherapeutics Inc
2% Upside
PHM
Pharma Mar SA
32% Upside
VOR
Vor Biopharma Inc
391% Upside
TRDA
Entrada Therapeutics Inc
59% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
44% Upside
LTRN
Lantern Pharma Inc.
444% Upside

Revenue
Forecast

Revenue Estimate
vTv Therapeutics Inc

For the last 10 years the compound annual growth rate for vTv Therapeutics Inc's revenue is -4%.

-4%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
vTv Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
vTv Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VTVT's stock price target?
Price Target
37.74 USD

According to Wall Street analysts, the average 1-year price target for VTVT is 37.74 USD with a low forecast of 35.35 USD and a high forecast of 42 USD.

Back to Top